MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Complement C4 Exacerbates Inflammation and Neuronal Damage in Vivo

    W. Zou, Y. Wang, Y. Xia, L. Kou, T. Wang (wuhan, China)

    Objective: To investigate the specific effects of the core complement component C4 on α-synuclein aggregation and neuroinflammation during the pathogenesis of PD. Background: Synucleinopathies are…
  • 2025 International Congress

    χ-DBS: An Open-Source Susceptibility Atlas Tool for Deep Brain Stimulation Target Visualization and Segmentation

    A. Roberts, J. Avecillas-Chasin, M. Spadaccia, S. Akkus, A. Dimov, M. Sisman, P. Spincemaille, T. Nguyen, B. Kopell, Y. Wang (Ithaca, USA)

    Objective: This work is motivated by the need for atlas creation tools for susceptibility maps presurgically acquired for deep brain stimulation (DBS). Segmentations aid in…
  • 2025 International Congress

    Differentiating Parkinsonism and related diseases by specific Parkinsonism patterns

    JX. Wang, B. Wang, XH. Chen, W. Luo (Hangzhou, China)

    Objective: This study aimed to identify characteristic parkinsonism patterns across PD, MSA and PSP, and evaluate their utility in early differentiation. Background: Parkinson's disease (PD), multiple…
  • 2025 International Congress

    Dopamine Transporter Imaging as a Predictor of Functional Outcomes in Parkinson’s Disease

    K. Niemi, V. Kaasinen, J. Joutsa (Turku, Finland)

    Objective: To evaluate the prognostic value of dopamine transporter (DAT) imaging in predicting future disability, as well as motor and non-motor burden, in Parkinson’s disease…
  • 2025 International Congress

    Dual task elicited premotor and supplementary motor activity as sensitive markers of mild Parkinson’s disease: an fNIRS analysis

    J. Longhurst, S. Conklin, Y. Chiu (Saint Louis, USA)

    Objective: This study aimed to explore dual-task (DT)-related cortical hemodynamic response (CHR) differences across healthy older adults (HOA), mild Parkinson’s disease (PD), and moderate PD…
  • 2025 International Congress

    A Multi-Transcriptional Risk Score Approach to Parkinson’s Disease Prediction

    L. Gilchrist, O. Pain, A. Noyce, K. Brolin, M. Periñán, P. Proitsi (London, United Kingdom)

    Objective: To improve the prediction of Parkinson’s disease (PD) by examining aggregate profiles of gene expression in the form of transcriptional risk scores (TRS). Background:…
  • 2025 International Congress

    Disclosing CLIA certified genetic results within the LARGE-PD Cohort in Peru: Preliminary results of the PD GENEration study

    A. Manrique-Palomino, F. Requejo-Navarro, M. Inca-Martinez, A. Rivera Valdivia, E. Sarapura-Castro, V. Marca, C. Armas, M. Illanes- Manrique, J. Rios-Pinto, K. Mejia-Rojas, A. Medina-Collque, I. Cornejo-Herrera, E. Ochoa-Valle, P. D. Hodges, R. de León, I. F. Mata, M. Cornejo-Olivas (Lima, Peru)

    Objective: To characterize the Peruvian Parkinson’s disease (PD) cohort within the Latin American Research Consortium on the GEnetics of Parkinson Disease (LARGE-PD) that received a…
  • 2025 International Congress

    16-years of Evaluations for Prodromal Parkinson Features in an At-Risk Cohort with Gaucher Disease

    E. Sidransky, E. Ryan, S. Nishimura, N. Tayebi, G. Lopez (Bethesda, MD, USA)

    Objective: To evaluate prodromal features of Parkinson disease in a cohort of "at-risk"  Gaucher patients and GBA1 carriers . Background: Variants in GBA1 mutations are…
  • 2025 International Congress

    VPS13C: a Modifier Gene causing Suboptimal Response to Levodopa in Early-Onset Parkinson’s Disease

    L. Malfer, C. Piat, O. Ross, Z. Niu, E. Benarroch, R. Savica (Jacksonville, USA)

    Objective: To describe a retrospective clinical study of four cases carrying heterozygous pathogenic variants in the VPS13C gene with a clinical diagnosis of Early-Onset Parkinson’s…
  • 2025 International Congress

    The Global Parkinson’s Genetics Program: Expanding the Diversity of Neurological Disorder Data: 2025 Update

    GP2. Parkinson'S_genetics_program (Chevy Chase, USA)

    Objective: To broaden the available data for Parkinson's Disease (PD) and related disorders by integrating genetic data from more than 115,000 participants worldwide through genotyping…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley